What is ANI Pharmaceuticals's inventories?

ANI Pharmaceuticals (ANIP) reported inventories of $143.47M in Q1 2026.

How has ANI Pharmaceuticals's inventories changed year-over-year?

ANI Pharmaceuticals's inventories increased by 4.4% year-over-year, from $137.41M to $143.47M.

What is the long-term trend for ANI Pharmaceuticals's inventories?

Over 5 years (2020 to 2025), ANI Pharmaceuticals's inventories has grown at a 18.7% compound annual growth rate (CAGR), from $60.8M to $143.07M.

What does inventories mean?

Total inventory including raw materials, work-in-progress, and finished goods, valued at the lower of cost or net realizable value.

ANI Pharmaceuticals ANIP Inventories

Inventories at other companies

Amneal Pharmaceuticals, Inc.AMRX

$641.62M+6.7%

ViatrisVTRS

$3.93B-4.1%

ALN

Alnylam PharmaceuticalsALNY

$84.03M+28.1%

Aurinia PharmaceuticalsAUPH

$46.41M+0.5%

AmgenAMGN

$6.19B-8.1%

Ultragenyx PharmaceuticalRARE

$55M+19.5%

Other financials

Income statement

See full

Revenue$237.5M+20.5%

Gross profit$143.9M+16.0%

Operating income$38.9M+48.5%

Net income$29.5M+88.1%

EPS (diluted)$1.28+85.5%

Balance sheet

See full

Cash & equivalents$311.2M+108%

Total debt$305.3M-3.5%

Total equity$562.3M+34.3%

Total assets$1.4B+10.0%

Cash flow

See full

Operating cash flow$58.4M+66.8%

CapEx$6.1M+146%

Free cash flow$52.3M+60.8%

Valuation

See full

Market cap$1.89B+18.3%

Enterprise value$1.88B+5.8%

P/E20.5×—

P/S2×-0.3×

Profitability

See full

Gross margin60.8%+1.5pp

Operating margin13.4%—

Net margin10%+8.1pp

FCF margin20.7%+10.8pp

Returns & leverage

See full

Return on equity18.8%+15.6pp

Debt / equity0.5×-0.2×

Current ratio3.1×+0.5×

Where this comes from

Reported directly by ANI Pharmaceuticals in its filing.

Tagged under the XBRL concept us-gaap:InventoryGross.

The official record: ANI Pharmaceuticals’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →

Ask your AI about ANI Pharmaceuticals's inventories.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is ANI Pharmaceuticals's inventories?: ANI Pharmaceuticals (ANIP) reported inventories of $143.47M in Q1 2026.
How has ANI Pharmaceuticals's inventories changed year-over-year?: ANI Pharmaceuticals's inventories increased by 4.4% year-over-year, from $137.41M to $143.47M.
What is the long-term trend for ANI Pharmaceuticals's inventories?: Over 5 years (2020 to 2025), ANI Pharmaceuticals's inventories has grown at a 18.7% compound annual growth rate (CAGR), from $60.8M to $143.07M.
What does inventories mean?: Total inventory including raw materials, work-in-progress, and finished goods, valued at the lower of cost or net realizable value.